Asset 1

Gentest® ADCC and CDC Assay Services

Evaluate tumor/cancer cell killing ability and assess complement-dependent safety issues.

Discovery’s antibody-dependent cell-mediated cytotoxicity (ADCC) assay services help assess your antibody's ability to facilitate effector cell-mediated cell killing by natural killer (NK) cells. Our experts can also help you screen your antibodies for complement events in our complement-dependent cytotoxicity (CDC) assay.

Gentest® ADCC Assay Service

Gentest® CDC Assay Services

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions